Patient P-02564

Synthetic patientMETA-24 · Day 180 · 55–64 · M · baseline S15Steering view · 3D Open companion preview

Therapy response

Unstable

Tolerance

Deteriorating

GI state

Deteriorating

Inflammatory state

Deteriorating

Nutritional resilience

Declining

Discontinuation risk

29%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S15
Day 22 Trajectory diverged from prediction — Observed response fell below the model's expected path.
Day 32 BR-03 recommended — Behavioural Recommendation BR-03
Day 33 Patient accepted — Started BR-03 in the companion
Day 40 GI symptom burden −17% vs expected — Behavioural Recommendation BR-03
Day 46 Tolerance state changed — Unstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 22.

Primary contributors, last 14 days

Toxicity+17
Inflammatory activity+15
GI instability+7
Nutritional resilience-4

What helped?

Behavioural Recommendation BR-03Day 32
Result: symptom burden −17%

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

54 min

worsening · -2.2 vs previous 14 d

Sleep duration

Wearable

6.1 h

worsening · -0.4 vs previous 14 d

Energy level

Daily log

4.6/10

worsening · -1.0 vs previous 14 d

Steps

Wearable

5,756

worsening · -407 vs previous 14 d

GI burden

Companion

25/100

worsening · +9.1 vs previous 14 d

Adherence

Companion

85.8 %

stable · +1.3 vs previous 14 d

Sleep quality

Wearable

24.8/100

worsening · -10.9 vs previous 14 d

Glucose, CGM daily mean

CGM

137 mg/dL

stable · +4.8 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 58 from the failing basin, 48 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -7.4 next day on high-intake days · n 20

Would not help

BR-03 Behavioural Recommendation
already tried, no meaningful change
Keep alcohol low
GI +4.8 next day on high-intake days · n 22

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-7.4supporter · 95%
Alcohol
+4.8detractor · 95%
Ultra-processed food
+2.3no signal · 47%
Histamine load
-1.7no signal · 29%
Caffeine
-1.1no signal · 17%
Dietary fat load
-0.7no signal · 15%
Insoluble fibre
-0.6no signal · 15%
Simple carbohydrates
-0.5no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↑35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 34 ms, trending down
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
Autonomic recovery ↓20
- WearableShort sleep window
Mucosal barrier integrity ↓10
- WearableSleep 6.1 h, below personal baseline

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure
GLP1R rs6923761 A
Altered receptor sensitivity

Microbiome

Shannon diversity 4.2 · butyrate capacity 52/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisHigh
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 39 ms
Sleep: 6.0 h
Steps: 4,882
Resting HR: 67 bpm

Daily log: GI score 25, nutritional resilience 62, adherence 86.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02016	42%	S20	DT-01	improved	27
P-02274	34%	S15	DT-01	improved	50
P-02484	33%	S15	GI-04	improved	49
P-02033	32%	S06	GI-04	improved	51
P-02037	32%	S04	GI-04	improved	53
P-02331	32%	S14	BR-03	improved	34
P-02391	32%	S19	HY-01	improved	53
P-02494	32%	S09	GI-04	improved	47
P-02150	31%	S11	HY-01	improved	45
P-02339	31%	S03	DT-01	improved	50
P-02455	31%	S09	DT-01	improved	50
P-02599	31%	S14	HY-01	improved	54